Advertisement
News
Advertisement

CMR Institute Adds e-Modules Addressing Healthcare Reform's Impact on Pharmaceutical Industry

Tue, 06/07/2011 - 12:35pm
Bio-Medicine.Org

ROANOKE, Va., June 7, 2011 /PRNewswire/ -- CMR Institute, the leading provider of non-brand related education for biopharmaceutical representatives and managers, announces the addition of two new e-modules to help representatives better prepare for changes created by the Affordable Care Act (ACA):

These new modules help representatives understand how key provisions of the ACA and elements of accountable care organizations (ACOs) will ultimately impact providers, payers, and patient care. As a result, reps will be more confident and better prepared to deliver value when interacting with physicians and other healthcare providers.

Key topics include:

  • Overview of Accountable Care Organizations (ACOs) and their role under the ACA
  • Understanding new quality mandates and reimbursement policies for providers
  • The role of national research institutes in monitoring and reporting patient outcomes
  • Changes in FDA approval for biologics
  • Comparative effectiveness research (CER) and its impact on evaluating treatment effectiveness

"In its current form, the Affordable Care Act will radically change how provider groups are reimbursed, initially for Medicare and Medicaid programs but eventually for other insured groups," says Cherie Hicks, CPA, President and CEO of CMR Institute. "Our new e-learning modules help repr

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading